Ad is loading...
RSLDX
Price
$69.58
Change
-$0.86 (-1.22%)
Updated
Nov 15 closing price
SMCFX
Price
$70.88
Change
-$0.87 (-1.21%)
Updated
Nov 15 closing price
Ad is loading...

RSLDX vs SMCFX

Header iconRSLDX vs SMCFX Comparison
Open Charts RSLDX vs SMCFXBanner chart's image
American Funds SMALLCAP World R5E
Price$69.58
Change-$0.86 (-1.22%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World F2
Price$70.88
Change-$0.87 (-1.21%)
VolumeN/A
CapitalizationN/A
RSLDX vs SMCFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSLDX vs. SMCFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLDX is a Buy and SMCFX is a Buy.

FUNDAMENTALS
Fundamentals
RSLDX (74.7B) and SMCFX (74.7B) have equal amount of cash in the bank . SMCFX (0.85) and RSLDX (0.83) have matching dividends . RSLDX was incepted earlier than SMCFX: RSLDX (9 years) vs SMCFX (16 years). RSLDX (29.00) and SMCFX (29.00) have comparable annual turnover. RSLDX (250) and SMCFX (250) have matching initial minimum investment requirements. SMCFX (16.27) and RSLDX (16.23) have marching annual gain over last year. SMCFX (20.68) and RSLDX (20.19) have equivalent 5 years return.
RSLDXSMCFXRSLDX / SMCFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years16 years-
Gain YTD3.9283.96099%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets74.7B74.7B100%
Annual Yield % from dividends0.830.8597%
Returns for 1 year16.2316.27100%
Returns for 3 years-25.42-25.25101%
Returns for 5 years20.1920.6898%
Returns for 10 yearsN/A43.16-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSA43.130.80
+1.89%
National Storage Affiliates Trust
CISS1.110.02
+1.83%
C3is
UTI19.610.07
+0.36%
Universal Technical Institute
TXT84.91-1.19
-1.38%
Textron
HRTX1.19-0.05
-4.03%
Heron Therapeutics